Fulcrum Therapeutics Inc (NASDAQ:FULC)
| 17.00 Delayed Data As of Jan 24 |  +0.13 / +0.77%Today’s Change | 4.37 Today|||52-Week Range 22.96 | +2.16% Year-to-Date |
Latest FULC News | Press Releases
No recent news for Fulcrum Therapeutics Inc.
Today’s Trading
| Previous close | 16.87 |
| Today’s open | 17.17 |
| Day’s range | 16.87 - 19.50 |
| Volume | 105,622 |
| Average volume (3 months) | 68,502 |
| Market cap | $396.1M |
Data as of 4:00pm ET, 01/24/2020
Growth & Valuation
| Earnings growth (last year) | -54.30% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | +47.26% |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | -- |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| PRQRProQR Therapeutics N... | +0.02 | +0.24% |
| VRCAVerrica Pharmaceutic... | -1.57 | -9.31% |
| PGNXProgenics Pharmaceut... | -0.06 | -1.28% |
| DRRXDURECT Corp | -0.10 | -4.76% |
Data as of 4:00pm ET, 01/24/2020
Financials
| Next reporting date | February 26, 2020 |
| EPS forecast (this quarter) | -$0.82 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$32.6M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Cambridge, Massachusetts |
Forecasts
